Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The France Journal.
Press releases published on April 18, 2025
Beautinow Expands Beauty Collection: Philip Kingsley, Heliocare, SKIN1004, Nuxe & Filorga
EIN Presswire
·
April 18, 2025
Beautinow.com has announced the expansion of its portfolio to include five premium beauty brands: Philip Kingsley, Heliocare, SKIN1004, Nuxe, and Filorga. ROTTERDAM, NETHERLANDS, April 18, 2025 /EINPresswire.com/ -- Beautinow.com has announced the …
Crave InfoTech Welcomes Holger Fritzinger as Strategic Advisor to Drive the Next Wave of SAP Innovation
EIN Presswire
·
April 18, 2025
Crave InfoTech appoints Holger Fritzinger as Strategic Advisor to advance SAP innovation and accelerate enterprise digital transformation. GERMANY, April 18, 2025 /EINPresswire.com/ -- As businesses worldwide accelerate their shift to AI, automation, …
Orange: Orange files an application to cease to be a reporting issuer in Canada
GlobeNewswire
·
April 18, 2025
Press release Paris, 18 April 2025 Orange files an application to cease to be a reporting issuer in Canada Orange S.A (“Orange”) has applied to the Autorité des Marchés Financiers (“AMF”) as its principal regulator in Canada and to the Ontario Securities …
Orange: Orange dépose une demande pour mettre fin à son statut d’émetteur assujetti au Canada
GlobeNewswire
·
April 18, 2025
Communiqué de presse Paris, le 18 avril 2025 Orange dépose une demande pour mettre fin à son statut d’émetteur assujetti au Canada Orange a sollicité auprès de l'Autorité des Marchés Financiers (« AMF »), son principal organisme de réglementation au Canada …
Dupixent® (dupilumab) Approved in the U.S. as the First New Targeted Therapy in Over a Decade for Chronic Spontaneous Urticaria (CSU)
GlobeNewswire
·
April 18, 2025
Approval based on Phase 3 trials demonstrating Dupixent significantly reduced itch and hives compared to placebo In the U.S., there are more than 300,000 adults and adolescents aged 12 years and older living with CSU who remain symptomatic despite …
Press Release: Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria
GlobeNewswire
·
April 18, 2025
Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria Approval based on phase 3 studies demonstrating Dupixent significantly reduced itch and hives compared to placebo In the US, there are more …
Communiqué de presse : Le Dupixent devient le premier nouveau médicament ciblé approuvé aux États-Unis depuis plus de dix ans pour le traitement de l’urticaire chronique spontanée
GlobeNewswire
·
April 18, 2025
Le Dupixent devient le premier nouveau médicament ciblé approuvé aux États-Unis depuis plus de dix ans pour le traitement de l’urticaire chronique spontanée Aux États-Unis, le Dupixent est indiqué à plus de 300 000 adultes et adolescents âgés de 12 ans et …
Valneva Provides Update on ACIP Recommendation for its Chikungunya Vaccine IXCHIQ® Among U.S. Travelers
GlobeNewswire
·
April 18, 2025
Saint Herblain (France), April 18, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that during its regular meeting on April 16, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory …
Valneva fait le point sur la recommandation de l'ACIP pour les voyageurs américains concernant son vaccin IXCHIQ® contre le chikungunya
GlobeNewswire
·
April 18, 2025
Saint-Herblain (France), le 18 avril 2025 – Valneva SE (Nasdaq : VALN ; Euronext Paris : VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui que lors de sa réunion ordinaire du 16 avril 2025, le comité consultatif américain sur les pratiques …